ERAS

Erasca, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$17.81

Market Cap

$5.54B

Beta

1.17

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+40.54%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.73%

Debt / Equity0.14

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for ERAS.